98%
921
2 minutes
20
Background: More than a third of out-of-hospital cardiac arrests in the European Union do not benefit from cardiopulmonary resuscitation by emergency medical services (EMS), most often because the patient shows signs of obvious death. To preserve limited resources, it is crucial for dispatch centres to identify such cases and thereby reduce over-triage. The aim of this study was to assess the ability of clinically trained dispatchers to detect obvious deaths among all suspected out-of-hospital cardiac arrests within a criteria-based dispatch system.
Methods: This retrospective single-centre study was conducted from June 2020 to January 2022. All calls in which dispatchers suspected an out-of-hospital cardiac arrest were included. Dispatchers’ decisions (priority versus non-priority dispatch) were used to determine whether obvious death was suspected. These were then compared to EMS’ decisions (resuscitation versus no resuscitation) to assess the appropriateness of the dispatch response.
Results: In total, 1,042 calls were included. Among the 335 patients confirmed as obviously dead by EMS, 80 received a non-priority dispatch (sensitivity: 23.9%). Among the 707 patients who were either resuscitated or not in cardiac arrest, 694 received a priority dispatch (specificity: 98.2%). Sensitivity increased to 33.1% when dispatchers actively searched for signs of obvious death. Of the 93 cases judged by dispatchers to be obvious deaths, 80 were confirmed (positive predictive value: 86.0%). Among the 949 patients in whom dispatchers did not suspect obvious death, 694 were resuscitated or not in cardiac arrest (negative predictive value: 73.1%).
Conclusions: The sensitivity of dispatchers in detecting obvious death was 23.9%, increasing to 33.1% when signs of obvious death were actively sought. In the context of limited EMS resources, it is vital to develop and implement protocols that reduce over-triage. For unwitnessed out-of-hospital cardiac arrests, a systematic search for clinical signs of obvious death appears essential.
Supplementary Information: The online version contains supplementary material available at 10.1186/s12245-025-00919-y.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12219122 | PMC |
http://dx.doi.org/10.1186/s12245-025-00919-y | DOI Listing |
Int J Mol Sci
August 2025
Department of Endocrinology and Internal Medicine, Medical College, Andrzej Frycz Modrzewski Krakow University, 30-705 Kraków, Poland.
Pituitary neuroendocrine tumors (PitNETs), also known as pituitary adenomas, are rare tumors that are usually benign. At present, the WHO PitNET classification based on transcription factors is in force. A problem is caused by invasive tumors and silent tumors which, despite a lack of obvious clinical symptoms, tend to behave aggressively.
View Article and Find Full Text PDFAntioxidants (Basel)
July 2025
Heilongjiang River Fishery Research Institute, Chinese Academy of Fishery Sciences, Harbin 150070, China.
Temperature fluctuations caused by climate change and global warming pose a threat to fish. The burbot () population is particularly sensitive to increased water temperature, but the systematic impacts of high-temperature exposure on their liver and intestinal health remain unclear. In January of 2025, we collected wild adult burbot individuals from the Ussuri River (water temperature: about 2 °C), China.
View Article and Find Full Text PDFmSphere
August 2025
Department of Virology III, National Institute of Infectious Disease, Musashimurayama, Tokyo, Japan.
Unlabelled: A previous study provides clinical evidence that extended respiratory virus detection can occur in healthy pediatric individuals. However, it remains unclear how long respiratory viruses can survive in the human respiratory tissue. In this study, the replication potential of common respiratory viruses was evaluated using air-liquid interface (ALI) cultures of primary human respiratory epithelial cells.
View Article and Find Full Text PDFToxicol Lett
August 2025
Department of Pharmaceutical Toxicology, Faculty of Pharmacy, İstanbul University, Istanbul, Türkiye.
Abemaciclib is a cyclin-dependent kinase (CDK) enzyme inhibitor approved by the FDA for advanced and metastatic breast cancer therapy. Abemaciclib has caused someadverse reactions, such as dermatitis and skin reactions; however, the underlying cellular mechanism is still not obvious. In the current study, human keratinocyte HaCaT cells were treated with 0-10 µM abemaciclib for 24 h.
View Article and Find Full Text PDFZh Vopr Neirokhir Im N N Burdenko
August 2025
Burdenko Neurosurgical Center, Moscow, Russia.
Introduction: The concept of «complex» aneurysm is now widely used in the planning of neurosurgical interventions. It is obvious that the definition and objectification of this concept should be separate for microsurgical and endovascular treatment.
Objective: Is to objectify the «complex aneurysm» concept with regard to endovascular treatment.